Correction to: May Measurement Month 2017: screening for hypertension in Nigeria-Sub-Saharan Africa [0.03%]
2017年世界血压日 Nigerian Sub-Saharan非洲国家高血压筛查/MMM2017校正版
[This corrects the article DOI: 10.1093/eurheartjsupp/suz064.]. © The Author(s) 2026. Published by Oxford University Press on behalf of the European Soc...
Optimizing protected PCI strategies in the setting of chronic kidney disease and advanced coronary artery disease: a clinical case-based discussion [0.03%]
慢性肾脏病和冠状动脉疾病经皮冠状动脉介入治疗策略优化的临床讨论
Mario Iannaccone,Jerzy Sacha,María Monteagudo-Vela et al.
Mario Iannaccone et al.
Patients with chronic coronary artery disease (CAD) and severely reduced left ventricular ejection fraction (LVEF) represent a particularly high-risk population often deemed unsuitable for conventional revascularization strategies. Procedur...
Patient selection for complex, high-risk indicated percutaneous coronary intervention procedures: an overview [0.03%]
复杂高风险经皮冠状动脉介入治疗术的患者选择：概要
Vasileios Panoulas,Ovidio De Filippo,Matthias Bossard et al.
Vasileios Panoulas et al.
Percutaneous coronary intervention (PCI) has evolved substantially over recent decades, enabling treatment of increasingly complex coronary anatomy through major technological advances, including enhanced stent platforms, intracoronary imag...
Protected percutaneous coronary intervention of complex distal left main disease with Impella CP™ support [0.03%]
Impella CP支撐下的复杂左主干远端病变保护性经皮冠状动脉介入治疗
Jan-Malte Sinning,Matthias Bossard,Christophe Vandenbriele et al.
Jan-Malte Sinning et al.
Complex distal left main (LM) coronary artery disease with bifurcation involvement and chronic total occlusion (CTO) is usually treated with coronary artery bypass grafting (CABG). Patient refusal of surgery necessitates high-risk percutane...
Impella™-protected PCI in a post-CABG patient with advanced biventricular dysfunction and mitral regurgitation [0.03%]
接受冠脉旁路移植术患者出现双室功能不全和二尖瓣反流现象后的TmPELLA™-PCI手术
Mohamed Ayoub,Saad Ezad,Roberto Lorusso et al.
Mohamed Ayoub et al.
Patients with advanced coronary artery disease (CAD), severely reduced left ventricular (LV) ejection fraction, and prior coronary artery bypass grafting (CABG) present with complex revascularization challenges requiring individualized, mul...
Contemporary evidence in protected percutaneous coronary intervention: a case-based review [0.03%]
经皮冠状动脉介入治疗的当代证据：基于病例分析
Ovidio De Filippo,Jürgen Leick,Giuseppe Tarantini et al.
Ovidio De Filippo et al.
High-risk percutaneous coronary intervention (PCI) in patients with markedly reduced left ventricular ejection fraction (LVEF) carries a substantial risk of haemodynamic collapse, creating an unmet need for strategies that allow complete, o...
Protected complex high-risk indicated percutaneous coronary intervention in severe left ventricular dysfunction: an illustrative case highlighting patient selection, procedural planning, execution, and device management [0.03%]
严重左心室功能不全患者的复杂高危PCI治疗：病例报告，重点介绍患者选择、手术规划、操作和器械管理
Saad M Ezad,Mohammad Alkhalil,María Monteagudo-Vela et al.
Saad M Ezad et al.
Ischaemic left ventricular dysfunction (ILVD) is the leading cause of heart failure and is commonly encountered in cardiac catheterization laboratories. Patients presenting with ILVD are typically older and often have complex coronary anato...
Optimizing revascularization in the high-risk heart: Impella™-facilitated percutaneous coronary intervention in multivessel coronary artery disease with reduced left ventricular ejection fraction and mitral regurgitation [0.03%]
左心室射血分数降低且合并多支冠状动脉病变和二尖瓣反流的高危患者经皮冠状动脉介入治疗中ImpellaTM的应用优化研究
Cristina Aurigemma,Jerzy Sacha,Pia Lanmüller et al.
Cristina Aurigemma et al.
Percutaneous coronary intervention (PCI) is considered for patients at high risk for peri-operative mortality and complications during coronary artery bypass grafting, with further consideration of mechanical circulatory support (MCS) to pr...
Protected PCI-contemporary evidence and experience in perspective: bridging the gap between guidelines and reality in high-risk coronary interventions [0.03%]
PCI保护策略的当代证据及现状：弥合高危冠脉介入治疗理论与实践差距的尝试
Nikos Werner,Vasileios Panoulas
Nikos Werner
ANMCO position paper: ANMCO general assembly 2024-the role of the cardiologist in the management of cardiovascular chronicity [0.03%]
意大利心内科医师学会立场文件：2024年ANMCO大会-心内科医师在心血管慢性病管理中的作用
Simona Giubilato,Pietro Scicchitano,Claudio Bilato et al.
Simona Giubilato et al.
Cardiovascular diseases remain the leading cause of mortality globally and in Italy, with a growing burden exacerbated by ageing populations and underdeveloped strategies for managing chronic cardiovascular conditions. This position paper, ...